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The present review attempts to provide an update of the scientific knowledge on the
renal toxicity which occurs in human subjects as a result of chronic ingestion of low-
level dietary Cd. It highlights important features of Cd toxicology and sources of
uncertainty in the assessment of health risk due to dietary Cd. It also discusses
potential mechanisms for increased susceptibility to Cd toxicity in individuals with
diabetes. Exposure assessment on the basis of Cd levels in foodstuffs reveals that
vegetables and cereals are the main sources of dietary Cd, although Cd is also found in
meat, albeit to a lesser extent. Cd accumulates particularly in the kidney and liver, and
hence offal contains relatively high amounts. Fish contains only small quantities of
Cd, while crustaceans and molluscs may accumulate larger amounts from the aquatic
environment. Data on Cd accumulation in human kidney and liver obtained from
autopsy studies are presented, along with results of epidemiological studies showing
the relationship between renal tubular dysfunction and kidney Cd burden. These
findings suggest that a kidney Cd level of 50 mg/g wet weight is a maximum tolerable
level in order to avoid abnormal kidney function. This renal Cd burden corresponds to
a urinary Cd excretion of 2 mg/d. Accordingly, safe daily levels of Cd intake should
be kept below 30 mg per person. Individual variations in Cd absorption and sensitivity
to toxicity predicts that a dietary Cd intake of 30 mg/d may result in a slight renal
dysfunction in about 1 % of the adult population. The previous guideline for a
maximum recommended Cd intake of 1 mg/kg body weight per d is thus shown to be
too high to ensure that renal dysfunction does not occur as a result of dietary Cd
intake.
Dietary cadmium: Cadmium body burden: Kidney toxicity: Zinc homeostasis: Diabetic
renal complications
FAO/WHO guideline on safe levels for intake of dietary
cadmium
Cd is a non-essential heavy metal, occurring naturally in Zn
and Pb ores and in some rock phosphate fertilizers (World
Health Organization, 1989; Resource Sciences, 1997;
McLaughlin & Singh, 1999). Industrial uses of the metal
and agricultural activities have now led to its widespread
dispersion at trace levels into the environment and human
foodstuffs (Galal-Gorchev, 1993; Australia New Zealand
Food Authority, 1998; Food and Agriculture Organization/
World Health Organization, 1998). This environmental
pollution by Cd has raised growing concerns about its
effects on the health of the general population since its
renal toxicity is well known (World Health Organization,
1989; International Programme on Chemical Safety, 1992;
Staessen et al. 1996; Jarup et al. 1998). This concern has
led to the establishment of a provisional tolerable weekly
intake (PTWI). The Joint FAO/WHO Expert Committee on
Food Additives defines the PTWI for a chemical with no
intended function as an estimate of the amount of the
chemical that can be ingested weekly over a lifetime
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without appreciable health risk (World Health Organiza-
tion, 1989). This estimate is not a no-effect level; it
provides an international guideline for monitoring global
Cd pollution and assessing the potential health risk caused
by Cd contamination of food. The PTWI first allocated to
cadmium was 400±500 mg per person per week. This level
was based on a critical concentration of 200 mg Cd/g
kidney cortex, attainable after a dietary Cd intake of 140±
260 mg/d for over 50 years or 2000 mg over a lifetime. In
1992, the PTWI was expressed more rationally in terms of
the intake per kg body weight, corresponding to 7 mg/kg
body weight per week or 1 mg/kg body weight per d
(World Health Organization, 1992). In 1993, while the
PTWI of 7 mg/kg body weight was retained (World Health
Organization/Food and Agriculture Organization, 1993), it
was recognised that the model on which the PTWI was
based did not include a safety factor and that there was only
a very modest safety margin between the exposure in a
normal diet and the level of exposure that produces
deleterious effects.
Assessment of dietary cadmium exposure
Levels of cadmium in foodstuffs
Cd appears as a contaminant in most foodstuffs (Galal-
Gorchev, 1993; Resource Sciences, 1997; Australia New
Zealand Food Authority, 1998; Food and Agriculture
Organization/World Health Organization, 1998). The
typical levels of the metal found in various kinds of food
are shown in Table 1. Cd levels in most vegetables,
including bulbs, roots and tubers, are usually below
0´05 mg/kg, although leafy vegetables such as spinach
and lettuce may have considerably higher levels. Some
wild mushrooms have been found to contain high levels of
Cd (1 mg/kg), even when they grow in uncontaminated
soil. The levels of Cd found in flour or bread are lower than
the levels found in grain, because Cd is present mainly in
the outer parts of the grain which is removed in the milling
process. For the same reason, Cd levels are higher in
wholemeal-type bread than other types. The average level
of Cd in bread is below 0´1 mg/kg. Wheat, in particular
durum wheat, may contain higher levels of Cd. Rice flour
usually contains less than 0´1 mg/kg.
Oilseeds, such as sunflower seeds, peanuts (Arachis
hypagaea) and linseed, accumulate Cd from the soil
independent of the Cd concentration in the soil (Food and
Agriculture Organization/World Health Organization,
1998). The Cd content in seed may exceed 0´5 mg/kg. Cd
levels found in sunflower kernels range from 0´2±2´5 mg/
kg (Li et al. 1995). Peanuts grown on soil low in Cd contain
levels less than 0´05 mg/kg (Wolnik et al. 1983; Resource
Sciences, 1997). In a similar manner to that of some
oilseeds, tobacco (Nicotiana spp.) efficiently accumulates
Cd in its leaves (Chaney et al. 1999). Cigarette smokers
may therefore absorb large amounts of Cd via the lungs, in
addition to dietary Cd via the gastrointestinal tract. Passive
uptake of Cd from the respiratory system is estimated to be
50 % (Elinder et al. 1976; Ellis et al. 1985).
The Cd levels in meat from muscle are of the order of
0´01 mg/kg for animals at slaughter, although they may be
higher in older animals. Cd concentrations in liver, and
particularly, kidney are substantially higher than that in
muscle. In the livers of calves, pigs and poultry, Cd levels
range from 0´02 to 0´2 mg/kg; these levels may also be
higher in older animals. Cd levels found in kidneys from
calves and pigs range from 0´05 to 0´5 mg/kg, while the
concentration in ox kidneys may approach 1 mg/kg. Horse
kidney and liver may have Cd concentrations exceeding
10 mg/kg.
Cd concentrations reported for fish muscle are about
0´02 mg/kg, although higher levels are found in some
species. Molluscs are known to accumulate Cd, indepen-
dent of environmental pollution, and normally have a Cd
concentration of 0´2 mg/kg. This concentration may be
considerably higher, however, due to accumulation of Cd
from contaminated waters (Food and Agriculture Organi-
zation/World Health Organization, 1998; Rayment, 1995).
`Brown' crab meat may contain Cd at levels above 10 mg/
kg. For example, the hepato-pancreas of spanner crabs
(Ranina ranina) was found to contain Cd at a level of
14´9 mg/kg (Rayment, 1995). Prawns captured in unpol-
luted or relatively-unpolluted Australian and international
waters sometimes have Cd concentrations in excess of
0´2 mg/kg. The Cd content of bluff oysters (Ostrea lutaria)
has been reported 27 mg/kg dry weight (McKenzie et al.
1986).
Based on the typical Cd content of the relevant foods, a
Table 1. Cadmium levels in foodstuffs and estimates of dietary cadmium exposure (adapted from Galal-Gorchev, 1993; Rayment, 1995; Food
and Agriculture Organization/World Health Organization, 1998; Resources Sciences, 1997; Australia New Zealand Food Authority, 1998)
Cd level (mg/kg)
Food item Maximum Typical
Intake level
(g/d)
Extreme exposure
(mg/d)
Typical exposure
(mg/d)
Vegetables, including potatoes 0´1 0´05 250 25 12´5
Cereals, pulses and legume, including rice and wheat grain 0´2 0´05 200 40 10
Fruit 0´05 0´01 150 7´5 1´5
Oilseeds and cocoa beans 1 0´5 1 1 0´5
Meat of cattle, poultry, pigs and sheep 0´1 0´02 150 15 3
Liver of cattle, poultry, pigs and sheep 0´5 0´1 5 2´5 0´5
Kidney of cattle, poultry, pigs and sheep 2 0´5 1 2 0´5
Fish 0´05 0´02 30 1´5 0´6
Crustaceans, molluscs 2 0´25 3 6 0´75
Total 93´5 30
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Cd intake of 30 mg/d has been estimated for the `average
consumer' (Table 1). Cereals and vegetables, including
potatoes, appear to account for more than 80 % of the
estimated total Cd intake. Meat, especially offal, accounts
for most of the remainder. Molluscs and crustaceans
normally only constitute a small part of the diet, and are
not considered to contribute much to the Cd intake. Fish
contains small quantities of Cd, and is not a major source of
dietary Cd. For the `extreme' consumer Cd intake is
estimated either by multiplying the typical exposure by 3 or
by using the highest Cd levels found in all relevant foods.
Such estimates give Cd intakes of 90 and 93´5 mg/d
respectively. These dietary Cd levels illustrate the narrow
safety margin between the level of exposure from a normal
diet and the level likely to produce deleterious effects.
There are particular concerns about the intake of Cd for
vegetarians or those who habitually consume diets high in
Cd, for example, due to high consumption of shellfish and
some seafood.
However, based on data from the 1996 Australian
Market Basket Survey (Australia New Zealand Food
Authority, 1998), Cd intakes in the range of 9±15 mg/d
were estimated for an average Australian consumer.
Potatoes, wheat, cocoa and meat contributed 46, 16, 12
and 7 % of the Cd in the diet respectively, while
crustaceans, liver, peanuts and vegetables each contributed
2±3 %, providing a further 11 % of the total intake. A
similar dietary Cd intake of 10±14 mg/d was estimated for
an average consumer in Germany, using data from the
German Market Basket Survey (Muller et al. 1998). The
relative contributions (%) of different food groups to
dietary Cd intake in the German survey were as follows:
bread, cake and pastries 41, potatoes 14, vegetables 10,
meat, sausage and fish 9; similar to the Australian findings.
Database estimation of dietary Cd intake probably
provides a reasonable method for estimating the relative
contributions of different food groups to dietary Cd intake.
Its use in health risk assessment, however, is questionable,
because of individual variations in kidney Cd concentra-
tions and sensitivity to Cd toxicity (Foulkes, 1993; Jarup
et al. 1998; Chaney et al. 1999). Its use in exposure
assessment needs to be validated by analysis of duplicate
diets. In a study on a sample of the US population, the
database calculation gave an estimate of a Cd intake of
about 24 mg/d; while an actual analysis of duplicate diets
estimated intake to be 56 mg/d (Reeves & Vanderpool,
1997). Thus, the database estimations in this instance
underestimated dietary Cd intake levels by 50 % although
the average Cd level of 56 mg in duplicate diets is within
the current guideline for safe intake level of 1 mg/kg body
weight per d.
Levels of cadmium in human kidneys and livers
An assessment of exposure to dietary Cd can also be
validated by measurement of the levels of kidney Cd in the
general population, since an average dietary intake appears
to be strongly related to kidney Cd levels (Morgan &
Sherlock, 1984). In two Australian autopsy studies an
average Cd level of 40 mg/g wet weight was found in
kidney cortex samples from a group of subjects aged upto
50 years (Miller et al. 1976; Spickett & Lazner, 1979). A
toxico-kinetic-based model used to estimate the dietary
intake of Cd suggested it was between 30 and 50 mg/d
(Miller et al. 1976). Although the two Australian autopsy
studies were carried out 20 years ago, and both smokers
and non-smokers were included, there has been no
indication of decreases in either food Cd content or
dramatic changes in dietary habits in Australia in the last
two decades. The Cd concentration in renal cortex samples
from 40±50-year-old men ranged from 7 to 43 mg/g wet
tissue weight in another autopsy study conducted recently.
Of sixty-one subjects, two subjects, both women, had renal
Cd concentrations of about 62 mg/g a concentration at
which toxicity may occur (S Satarug, JR Baker, PEB
Reilly, MR Moore and DJ Williams, unpublished results).
Thus, the average dietary Cd intake of 9±15 mg/d derived
from modelling of the 1996 Australian Market Basket
Survey data (Australia New Zealand Food Authority,
Table 2. Human liver and kidney cadmium concentrations (mg/g wet tissue weight)
(Values are means, except in the study of Tiran et al. (1995) where values are medians)
Age-group (years) Reference Country of origin
Fetal (n 9) 1±20 (n 1) 21±40 (n 8) 41±60 (n 13) >61±80 (n 52) 81±90 (n 6) Chung et al. (1986) Canada
Liver ND 1´0 1´7 2´3 2´2 0´7
Kidney ND 5´4 26´3 41´8 16´4 6´8
12±18(n 2) 25±36(n 7) 45±59(n 7) 61±69(n 8) 70±79(n 8) 84±87(n 4) Tiran et al. (1995)* Austria
Liver 0´16 0´62 1´51 0´56 0´78 0´79
Kidney 3´68 6´38 5´80 10´04 6´72 8´05
0±9(n 7) 10±29(n 56) 30±39(n 34) 40±59(n 83) 60±79(n 80) 80±99(n 31) Elinder et al. (1976) Sweden
Liver 0´26 0´56 0´60 0´77 1´04 0´59
Kidney 2´39 8´83 17´96 19´92 15´02 7´06
0±1(n 6) 2±20(n 10) 21±40(n 10) 41±60(n 12) 61±95(n 12) Yoshida et al. Japan
Liver 0´05 1´12 2´29 1´88 3´55 (1998) non-polluted area
Kidney 0´61 8´41 33´3 69´8 52´3
* Non-smokers only were included; all other studies included both smokers and non-smokers.
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1998), appears to be too low to account for these recorded
renal Cd levels in Australians.
Human liver and kidney Cd levels obtained from autopsy
studies conducted in Canada, Austria, Sweden and Japan
are summarized in Table 2. Occupationally-exposed
subjects were not included in any of these studies. The
Austrian study included only non-smokers, while the
Canadian, Swedish and Japanese studies included both
smokers and non-smokers. All three studies indicate that
kidney Cd concentration increases progressively with age,
reaching a peak at 40±60 years. Kidney Cd concentrations
were lower in subjects over 60 years old than in those in
some younger age-groups. Lower renal Cd levels in
subjects over 60 years old may represent increased
exposure to Cd in recent times. It may also represent Cd
loss from damaged kidneys or age-related degeneration of
kidneys, since no further accumulation of Cd was found in
damaged kidneys despite continued exposure (Ellis et al.
1981). Under these conditions, the renal levels were found
to fall, even though the amounts of Cd in the liver may
continue to increase. In accordance with this view, Cd
concentration in the kidneys of subjects dying of renal
disease was found to be markedly lower than that from
subjects dying of other diseases (Lyon et al. 1999).
The liver Cd concentration, although gradually increasing
with age, does not show a decline in older age-groups. The
average liver Cd concentration found in the 40±60 years age-
groups ranges from 0´77 to 2´3 mg/g. In contrast to lower
levels of liver Cd, the average kidney Cd content of the 40±
60 years age-groups recorded in these studies range from
19´92 to 69´8 mg/g. These values were 20±40-fold greater
than those for the liver. In the Austrian study, which included
only non-smokers, the highest renal Cd concentration
(10 mg/g kidney cortex) was found in the 61±69 years age-
group. This value is 18-fold greater than the liver Cd level
found in the same age-group. This consistent preferential
accumulation in the kidney appears to be a feature of chronic
exposure to low-level dietary Cd. It is attributable in part to
slow mobilization of Cd from the liver and other tissues to the
kidneys, probably in metallothionein (MT)-bound form
(Dudley et al. 1985; Chan et al. 1993). Such preferential
kidney accumulation has also been attributed to the role of
intestinal MT (see p. 797).
In contrast to low-level dietary exposure, inhalation of
Cd in dust and fumes in the workplace gives rise to high Cd
levels in both the liver and kidney. Cd levels of 42´3 and
110 mg/g respectively were found in the liver and kidney of
occupationally-exposed subjects (Ellis et al. 1984). These
Cd levels give rise to a 50 % probability of having kidney
damage and dysfunction (Ellis et al. 1984; Lauwerys et al.
1994). A more recent study in workers in the battery
manufacturing industry confirms high Cd levels in both the
liver and kidney as a feature of non-dietary exposure
(Borjesson et al. 1997). In chronic low-level exposure a
renal Cd level of 200 mg/g may give rise to a 10 %
probability of having kidney dysfunction in some human
populations (Ellis et al. 1983; Foulkes, 1993). In `high-risk'
groups, this renal Cd level, however, may give rise to a 50
% probability of having kidney dysfunction (Buchet et al.
1990; Jarup et al. 1998).
In the Swedish study (Elinder et al. 1976), it was noted
that smokers had about 2-fold greater kidney Cd concen-
trations than non-smokers, and that most of the individuals
with kidney Cd concentrations over 50 mg/g were women.
A large British autopsy study (Lyon et al. 1999), which
included only kidney samples, showed that levels in
kidneys of smokers were on average 5 mg/g higher than
those of non-smokers and the 40±59 years age-group had
an average kidney Cd of 23 mg/g. Variations in renal Cd
accumulation from cigarette smoke recorded in different
human population studies may be due to varying Cd
content of tobacco leaves (Elinder et al. 1983). The British
study (Lyon et al. 1999) also suggested that kidney Cd
levels were static over the 16-year period (1978±1993), but
were higher than those found in studies done in the 19th
and early 20th century. The distribution of kidney Cd
concentrations was skewed, with about 3´9 % of the 2700
samples above 50 mg/g, although the population mean
value for kidney Cd concentration was only 19 mg/g.
Data from human autopsy studies suggest that the biological
half-life of kidney Cd is 30 years (Elinder et al. 1976). On this
basis, a toxico-kinetic model of Cd uptake, distribution and
excretion was developed, which includes an oral absorption
rate of 5 % and a daily excretion rate of 0´005 % of the body
burden, one-third of which is in the kidney (Elinder et al.
1978; Buchet et al. 1990). The model predicts that the Cd-
level of 50 mg/g kidney cortex may be attained after 50 years
on a dietary Cd intake of about 1 mg/kg body weight per d,
which is equivalent to the current guideline for safe levels of
dietary Cd intake (Elinder et al. 1976).
Renal toxicity and the maximum tolerable dose
Renal tubular damage caused by Cd is known to be
irreversible (International Programme on Chemical Safety,
1992; Jarup et al. 1998). The damage causes decreased
reabsorption capacity, and hence loss from the body of
otherwise reabsorbed solutes. Such solutes may include MT
with firmly bound Zn and Cu, and a range of low-
molecular-weight compounds such as glucose, amino acids,
phosphate, Ca, b2-microglobulin, retinol-binding protein,
and possibly vitamin C (International Programme on
Chemical Safety, 1992; Lauwerys et al. 1994). Urinary
excretion of the metal itself, along with other small solutes
and enzymes of renal tubular origin, such as N-acetyl-b-D-
glucosaminidase (NAG), therefore provide useful indica-
tors of renal tubular function. The level of Cd excreted in
the urine is considered to reflect body burden or long-term
exposure, before development of renal damage, whereas
blood Cd is an indicator of more recent exposure
(Lauwerys et al. 1994; Jarup et al. 1998).
Manifestation of Cd toxicity, such as increased urinary
excretion of low-molecular-weight proteins, e.g. b2-micro-
globulin and retinol-binding protein, appear to be impli-
cated in long-term prognosis. A 40±80 % increased annual
mortality risk has been recorded for subjects with Cd-
induced kidney damage in three different areas of Cd
pollution in Japan (Iwata et al. 1992; Nakagawa et al. 1993,
1996; Nishijo et al. 1999). In addition, increased urinary Cd
and b2-microglobulin levels were found to be associated
with mortality in a dose-dependent manner (Nishijo et al.
1999). Increased risk of renal stone formation has also been
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found in subjects with occupational exposure to Cd
(Staessen et al. 1996; Jarup et al. 1997, 1998). A parallel
may be made with diabetic patients, who show increased
urinary excretion of microalbumin, a symptom of abnormal
capillary leakage. This factor is, in fact, an early warning of
renal complications, subclinical or clinical morbidity, and
mortality (Peters et al. 1996; Lupaz, 1997; Mogensen,
1998; Sheth, 1999). Early intervention can retard the
progression of microalbuminuria to end-stage renal failure.
Similarly, if Cd exposure is eliminated, or minimised, the
progression to chronic renal failure may be prevented.
Analysis of the relationship between occurrence of renal
dysfunction and urinary Cd excretion in the general
population reveals that renal Cd levels associated with
slight kidney dysfunction may be lower than previously
estimated. The Cadmibel study (Buchet et al. 1990),
conducted on 2327 subjects in Belgium during 1985±9,
found a 10 % probability of having renal dysfunction when
urinary Cd excretion exceeded 2±4 mg/d. This value was
derived from a logistic regression of Cd renal burden
(urinary Cd) and various indicators of renal damage,
including urinary excretion of Ca, amino acids, NAG,
retinol-binding protein and b2-microglobulin. More than
10 % of values were found to be abnormal when Cd
excretion (mg/d) exceeded 1´92 for Ca, 4´29 for amino
acids, 2´74 for NAG, 2´87 for retinal-binding protein and
305 for b2-microglobulin. In this study, a cut-off value of
283 mg/d for b2-microglobulin was used to reflect
abnormal values (Buchet et al. 1990). The Japanese studies
used a cut-off value of 1000 mg b2-microglobulin/g
creatinine, the level at which renal impairment was
considered to be irreversible. They found that urinary Cd
levels exceeding 1´6±3´0 mg/g creatinine for men and 2´3±
4´6 mg/g creatinine for women indicated an excess
prevalence of renal dysfunction (Hayano et al. 1996;
Yamanaka et al. 1998). A study in China found a 9´1 %
increase in urinary excretion of b2-microglobulin to be
associated with a rise in urinary Cd excretion from 0±4 mg/
g creatinine to 4±8 mg/g creatinine (Cai et al. 1998).
The levels of urinary Cd found to be associated with
excess risk of renal tubular dysfunction in these studies
correspond to a kidney Cd level of $50 mg/g kidney cortex
(Buchet et al. 1990). This value is well supported by one
recent autopsy study conducted on thirty-nine subjects, 10±
72 years of age, which found a urinary Cd level of 1´7 mg/g
creatinine in subjects with a kidney Cd level of 50 mg/g
(Orlowski et al. 1998). The use of urinary Cd to give some
estimates of renal Cd burden also proved to be valid in a
study of 30±59-year-old non-smoking Korean women
(Moon et al. 1998, 1999). Thus, it is reasonable to infer
from these studies that renal Cd of approximately 50 mg/g
is a maximum tolerable internal dose to avoid abnormal
kidney function. This level corresponds to a urinary Cd
excretion of 2 mg/d. Strong correlations between concen-
trations of Cd in rice and significant increases in urinary
excretion of b2-microglobulin, glucose, amino acids and
MT were found in Japanese people who had lived in Cd-
polluted areas for at least 30 years and consumed home-
grown rice (Nakashima et al. 1997). Further, regression
analysis of data revealed that the Cd content of rice needed
to be less than 0´4 mg/kg in order to avoid occurrence of
renal dysfunction (Nakashima et al. 1997). Evidence for Cd
renal toxicity was found in a sample of the Chinese
population who consumed rice containing Cd at a level of
3´7 mg/kg (Nordberg et al. 1997). This level is approxi-
mately 10-fold greater than the safe limit suggested in the
Japanese study (Nakashima et al. 1997).
Nephrotoxic potential of cadmium in sunflower kernels
v. bluff oysters
Cd accumulation and toxicity in the kidney is known to be
a function of the chemical form of the metal and the
presence of certain other elements in the diet, as well as
individual sensitivity (Buchet et al. 1990; Foulkes, 1993;
Jarup et al. 1998; Chaney et al. 1999). Apart from Cd in
rice, our knowledge of the nephrotoxic potential of Cd
in other foodstuffs is very limited. The studies on Cd in
sunflower kernels and bluff oysters discussed in the present
review are among the few studies that have been done in
human subjects. Due to inherent genetic and physiological
characteristics, sunflower has a high rate of Cd uptake from
soil, and this is deposited in the kernels (Li et al. 1995).
Thus, sunflower kernel has a higher concentration of Cd
than most other grains, ranging from 0´2 to 2´5 mg/kg wet
weight.
The bioavailability of Cd in sunflower kernels has been
demonstrated in rats (Reeves et al. 1994) and a study of the
nephrotoxic potential of sunflower kernels was performed
in subjects who habitually consume sunflower kernels
(Reeves & Vanderpool, 1997). Seventy-five male and
female non-smokers, aged 30±70 years, were included in
the study. Based on a self-reported food-frequency survey,
subjects who reported consuming more than 28 g sunflower
kernels per week were classed as high consumers. Actual
analysis of duplicate diet showed that control subjects who
consumed few sunflower kernels had an average dietary Cd
intake of 36 mg/d. However, food analysis was not done for
any of the high consumers. Blood concentrations and
urinary excretion of Cd were used as indicators of Cd body
burden. The urinary excretions of b2-microglobulin and
NAG were used as markers for Cd toxicity and evidence of
renal toxicity was found in the high consumers. The limited
number of subjects recruited in the study and individual
variations in Cd absorption, however, meant that the
expected increased Cd body burden among the high
consumers could not be demonstrated.
Cd toxicity may occur if the Cd in sunflower kernels is
absorbed and delivered to kidneys in an MT-bound form
(Cd7MT), since the rate at which Cd is presented to the
kidneys has been shown to be important in the manifesta-
tion of toxicity of this metal (Wahba & Waalkes, 1990;
Foulkes, 1993; Sudo et al. 1994). In chronically-exposed
rats hepatic damage was found to precede nephrotoxicity,
and hence hepatic Cd probably reached the kidneys largely
in the hepatic MT-bound form (Dudley et al. 1985). In the
protein-bound form, up to seven Cd atoms/mol MT gain
entry to the proximal tubule cells. To support this
hypothesis, injection of Cd-bound MT has been shown to
result in greater accumulation of renal Cd and renal damage
than equimolar injections of CdCl2 (Dorian et al. 1992;
Wang et al. 1993). Further, acute renal toxicity can be
795Human cadmium exposure and renal toxicity
https://doi.org/10.1017/S0007114500002403
Downloaded from https:/www.cambridge.org/core. UQ Library, on 07 Feb 2017 at 05:44:58, subject to the Cambridge Core terms of use, available at https:/www.cambridge.org/core/terms.
induced in rats by a single injection of Cd (0´3±0´4 mg/kg
body weight) bound to MT either with Zn (Cd5Zn2MT) or
without Zn (Cd7MT). These treatments gave rise to renal
Cd concentrations of only 5±9 mg/g (Sudo et al. 1994; Liu
et al. 1998). Taken together, the results of these studies
indicate that Cd in sunflower kernels may have a high
nephrotoxic potential. Alternatively, they may indicate
increased sensitivity to Cd toxicity in the high sunflower-
kernel consumers.
Another study, conducted on subjects associated with the
oyster industry in New Zealand (McKenzie et al. 1986),
investigated the short-term (6 months) relationships
between intake of high-Cd foods (bluff oysters), Cd body
burden, and toxicity. The study included fifty-seven men
and nineteen women in the age range 20±75 years. Based
on their oyster intakes, the subjects were divided into four
groups with average consumptions of ,6, 6±24, 24±,72
and $72 oysters per week for groups 1, 2, 3 and 4
respectively. The estimated Cd intake (mg/d) for subjects in
groups 1, 2, 3 and 4 were 34, 75, 116 and 250 respectively.
The concentration of Cd in whole blood was found to be
higher in smokers than in non-smokers. In the non-smokers,
the increase in whole-blood Cd attributable to oyster
consumption was 1´2 mg/l for subjects in group 4. The
concentration of Se in whole blood was also elevated by
oyster consumption, but serum concentrations of Zn or Cu
were not affected. The concentrations of Cd, Zn and b2-
microglobulin in the urine were not affected, and there was
no glycosuria or proteinuria that was attributed to a high Cd
intake. None of the subjects had a b2-microglobulin
concentration greater than 250 mg/l. Hair Cd, Zn and Cu
levels were not affected by oyster consumption. It was
concluded that interactions with Se and other trace
elements in oysters may result in diminished absorption
of Cd. Although dietary Se and Zn were measured in the
study, other important determinants of Cd absorption and
renal accumulation, such as Fe content in the oysters and Fe
status of the subjects, were not taken into account.
Furthermore, short-term effects and the small number of
subjects, especially women, did not allow demonstration of
the expected increased Cd body burden among the high
bluff oyster consumers. Nevertheless, it showed that the
bioavailability of Cd in bluff oysters appeared to be
relatively low. However, truly comparative bioavailability
of Cd in different foods cannot be made based on human
study data because of known individual variations in
absorption.
Absorption as a potential source of variation in renal
cadmium burden
The absorption rate of Cd is estimated to be between 3 and
7 % in human subjects and 0´3±3´5 % in rat (World Health
Organization, 1989; International Programme on Chemical
Safety, 1992). A 5 % absorption rate has been used in
health-risk assessment procedures and this level is
considered to be conservative. Recent studies, however,
indicate that up to 20 % of the Cd may be absorbed from
the gastrointestinal tract (Diamond et al. 1997). Also, the
British autopsy study (Lyon et al. 1999) showed that
individual variations in dietary intake, absorption, and
excretion of Cd account for a large percentage (about
92 %) of the variation in renal Cd accumulation, while age
and smoking were found to explain only 8 % of the
variation. The rate of mobilisation of liver Cd to the kidney
may be variable among individuals, and this variability
may need to be considered as another potential source of
variation in renal Cd burden. A study in our own laboratory
(S Satarug, JR Baker, PEB Reilly, MR Moore and DJ
Williams, unpublished results) using a variant strain of
Wistar rats that has lost the ability to synthesise vitamin C,
suggested that vitamin C status and NO production in
response to immunostimulants may enhance mobilisation
of Cd to the kidney.
Role of individual status for micronutrients and essential
elements in absorption
Age, status of micronutrients and essential elements,
notably vitamin C, Fe, Ca, and Zn, have been found to
influence Cd absorption (Elsenhans et al. 1997; Brzoska &
Moniuszko-Jakoniuk, 1998). The rate of Cd absorption is
increased substantially when the body is in short supply of
elements with common absorption and transport mechan-
isms. This increased absorption has been demonstrated in
subjects with dietary Fe deficiency (Flanagan et al. 1978;
Vahter et al. 1996). Increased absorption of Cd from a
high-shellfish diet was found in women with low body Fe
stores (Vahter et al. 1996). Cd intake levels, assessed by
duplicate diets, were found to be 11 and 28 mg/d
respectively for women in the mixed-diet and high-shellfish
diet groups respectively. No differences in blood or urine
concentrations were seen in the two groups when all
subjects were considered. However, a 63 % increase in
blood Cd concentration and a 24 % increase in urine Cd
concentration were found in women who consumed high-
shellfish diets and had a plasma ferritin level of less than
20 mg/l compared with those who consumed mixed diets
and had the same low body Fe stores (Vahter et al. 1996).
Several studies have shown that women have higher
concentrations of Cd in blood, urine and kidneys than
men (Elinder et al. 1976; Watanabe et al. 1989; Buchet
et al. 1990; Lin et al. 1995; Jarup et al. 1998). In general,
women have lower body Fe stores than men, and hence the
increased body Cd burden in women may be due to
increased absorption and/or other toxico-kinetic variables
(Jarup et al. 1998; Jin et al. 1998). One recent study
reported that female Balb/c mice infected with Coxsackie
virus showed a 70 % increase in absorption of Cd when Cd
was administered by intubation at the dose of 0´3 mg/kg
body weight, using 109Cd as a tracer (Glynn et al. 1998). In
the same study Cd absorption was found to be tripled at a
Cd dose of 750 mg/kg body weight.
Individuals with haemochromatosis who absorb abnor-
mally high amounts of Fe from foods may also absorb more
Cd. Recently, the intestinal protein involved in dietary Fe
absorption (Nramp2) has been reported to bind to many
divalent ions, including Cd and Pb (Gunshin et al. 1997;
Fleet, 1998; Wood & Han, 1998). Increased expression of
Nramp2 in subjects with haemochromatosis or low body Fe
stores in general, would provide them with a greater
capacity to absorb Fe and possibly Cd.
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Similarly, increased expression of Ca-binding protein in
the epithelium of intestinal villi could enhance Cd
absorption, whereas high dietary Ca could compete with
the binding of Cd by the protein, and hence lower Cd
absorption (Brzoska & Moniuszko-Jakoniuk, 1998). The
interactions between dietary Cd and components in Ca
absorption remain to be elucidated, especially in human
subjects.
Role of intestinal metallothionein
It has been proposed that intestinal MT may play an
important role in absorption, transport and distribution of
dietary Cd to the kidney (Elsenhans et al. 1992, 1997). If
this mechanism is in operation, dietary Cd would be
deposited directly in the kidneys since Cd in MT-bound
forms (Cd7MT and Cd5Zn2MT) has been shown to be taken
up largely by kidney (Dorian et al. 1992; Sudo et al. 1994;
Liu et al. 1998). This hypothesis appears to challenge the
previous notion that hepatic Cd accumulation takes place
before renal accumulation. However, only high oral doses
of Cd salts appear to give initially high liver Cd levels. In
contrast, higher levels of Cd were seen in kidney than liver
in rats fed the diet containing Cd at levels of 0´03±3 mg/kg
(Scheuhammer, 1988; Elsenhans et al. 1992, 1997). These
levels of Cd in rat diets are similar to those found in human
foodstuffs (see Table 1). Also in rats, Cd levels were found
to be higher in the kidney than in the liver 1, 4 and 8
months after feeding with contaminated rice containing Cd
in the range 0´1±1´0 mg/kg (Hiratsuka et al. 1999). Higher
Cd levels were found in the kidney than in the liver in every
age-group in the human autopsy studies conducted on non-
occupationally-exposed subjects (Table 2).
If intestinal MT plays an important role in dietary Cd
absorption and renal accumulation, variability in the
amount of Cd absorbed from various foods may be
accounted for by the capacity for different food compo-
nents to affect expression of this intestinal protein.
Although there is little information on levels of intestinal
MT in human subjects, the very high degree of inducibility
of this protein in the liver is well-known (Bremner, 1993;
Kagi, 1993; Cousins, 1994; Palmiter, 1998). Correlations
between liver MT, Cd and Zn levels found in human
autopsy studies suggest that Cd may have induced increases
in MT levels in the liver (Chung et al. 1986; Lopez-
Artiguez et al. 1995; Torra et al. 1995; Yoshida et al.
1998). Increased expression of MT was found in erythro-
cytes and monocytes from 19±35-year-old men who had
received Zn supplements at a dose of 50 mg/d for 18 d
(Sullivan et al. 1998). In rats, intestinal MT has been found
to be induced by Cd, Zn and Cu, but not by Ni or Pb
(Tandon et al. 1993).
Dietary flavonoids have been shown to interact with Cu
and Fe, as well as to influence expression of MT (Kuo et al.
1998). Quercetin decreased MT levels in cultured human
intestinal cells Caco-2, while genistein and biochanin
increased the protein levels. The role of flavonoids in Cd
absorption, however, remains to be elucidated. In contrast,
Ca, Zn, Fe and fibre levels in the diet have been found to
have a strong influence on Cd absorption and renal
accumulation (Wing, 1993; Rimbach & Pallauf, 1997;
Brzoska & Moniuszko-Jakoniuk, 1998; Lind et al. 1998).
The mechanism for these interactions remains unclear.
A 70±80 % reduction in Cd accumulation in the liver
and kidneys was found in rats after 8 weeks of feeding Cd-
containing food supplemented with Ca, P, Fe and Zn
(Groten et al. 1991). The reduction in Cd accumulation was
attributed to the presence of Fe2+. The addition of vitamin
C improved Fe uptake, but did not decrease Cd accumula-
tion. Fe in combination with Ca, P and Zn gave the most
pronounced effect. In this study, however, high doses of Cd
were used (the daily intake of Cd was 0´17±0´36 mg per
rat, equivalent to 1´5±2´5 mg Cd/kg body weight per d). It
remains to be seen whether such an effect of Fe on Cd
accumulation is present at Cd levels close to the current
Food and Agriculture Organization/World Health Organi-
zation (1998) recommended safe level of intake (1 mg/kg
body weight per d). Nevertheless, this study calls for
special consideration to be given to an adequate intake of
Fe in the health-risk assessment of Cd in foods.
Diets high in phytate (high in fibre) have been found to
enhance absorption and retention of Cd in the kidney in
some experimental animals (Rimbach & Pallauf, 1997).
Such effects require further studies involving a wider range
of fibre sources and animal species, since they could be of
particular concern to the general human population, in
which dietary habits are changing towards higher intake of
fibre-rich foods. Supplementation of food commodities
with citric acid, which is a common practice, enhances the
bioavailability of essential metals such as Zn, and may also
result in increased absorption of Cd (Walter et al. 1998).
Interaction between renal cadmium burden and
diabetes mellitus
The Cadmibel study in Belgium revealed for the first time
that diabetic patients show increased susceptibility to the
renal toxicity of Cd (Buchet et al. 1990). Subsequent
animal studies have shown that the symptoms of diabetic
renal complications and Cd renal toxicity are enhanced
when both the metal and the disease are present. Injection
of Cd bound to MT resulted in increased urinary excretion
of proteins and Ca in both diabetic obese mice and non-
obese littermate controls (Jin et al. 1994). In the diabetic
obese mice, however, about 4-fold lower Cd doses gave the
same increases in urinary excretion of proteins and Ca as
those of the controls. In both groups, the Cd treatment
resulted in increases in urinary glucose excretion in a Cd-
dose-dependent manner, despite decreases in blood glucose
and insulin. Thus, such findings suggest that glycosuria
may be an indicator of the nephrotoxicity of Cd,
particularly in experimental diabetes. Hereditary diabetic
Chinese hamsters also appeared to be more susceptible to
Cd renal toxicity (Jin & Frankel, 1996). In type I Diabetic
rats, kidney Cd concentrations of 10±40 mg Cd/g wet
weight were found to enhance urinary excretion of
albumin, transferring and immunoglobulin, a feature of
diabetic renal complications (Bernard et al. 1991). How-
ever, no Cd-related toxicity was seen at any of these renal
Cd concentrations. Hence, a Cd renal burden at levels lower
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than the threshold for toxicity (less than 50 mg/g wet
weight in human subjects) may enhance development of
diabetic renal complications without concurrent nephro-
toxicity. The mechanisms underlying the involvement of
Cd in the development and progression of diabetic
nephropathy need further study.
Increased tissue Zn concentrations following Cd induc-
tion of the metal-binding protein MT may lead to changes
in the activity of Zn-dependent enzymes in glucose
metabolism, most probably in the liver. A deficit in hepatic
gluconeogenesis has been observed in MT-null mice that
cannot accumulate Zn in the liver and lose hepatic Zn in
response to endotoxin injection (Philcox et al. 1995; Rofe
et al. 1996). This observation supports the role of Zn and a
11´5 kDa Zn-binding protein in hepatic glucose metabolism
(Brand & Heinickel, 1991). Incubation of hepatocytes from
rats fed Zn increased the rate of lactate and glucose
production (Brand & Kleineke, 1996). Cd concentrations
ten times lower than those of Zn (8 mM v. 80 mM) gave the
same effect, probably via a Zn-displacement mechanism
due to their similar chemistry, but Cd has a higher affinity
for S ligands than Zn (Waalkes et al. 1992). Indeed, Cd has
been shown to displace Zn in the Cys2Cys2- and Cys2-His2-
Zn fingers of steroid hormone and transcription factor III A
(Hanas & Gunn, 1996). Our own study conducted on male
Wistar rats showed that Cd displacement of Zn bound to
renal MT occurs under in vivo conditions (Satarug et al.
2000). The effects of Cd on enhanced gluconeogenesis
have yet to be shown in the kidney. Such studies may
explain the glycosuria caused by injection of Cd-bound MT
in obese diabetic and non-obese littermate control mice
discussed earlier (p. 797).
In the Cadmibel study, individuals with a high body Cd
burden, as assessed by urinary Cd, had on average 5 %
lower serum Zn levels (Thijs et al. 1993; Staessen et al.
1996). This result was obtained after adjustment for effects
of age and other significant covariants, and was not altered
when occupationally-exposed subjects were excluded from
the analysis. Redistribution of Zn from the labile pool into
tissue, particularly the liver, probably caused the small
reduction in serum Zn. In support of tissue redistribution,
Zn, Cd and MT levels in human livers were found to be
positively correlated (Chung et al. 1986; Lopez-Artiguez
et al. 1995; Torra et al. 1995; Yoshida et al. 1998). In
diabetic patients similar perturbations of Zn homeostasis
may occur (Wolff, 1993; Isbir et al. 1994; Williams et al.
1995; Escobar et al. 1995). High-dose Zn supplementation,
however, was found to be potentially toxic in insulin-
dependent diabetic patients. The levels of haemoglobin Alc
in these patients were increased markedly after 28 d of Zn
supplementation at 50 mg/d (Cunningham et al. 1994).
Hence, protein glycosylation appeared to be enhanced
when Zn was in excess. Higher levels of glycosylated
haemoglobin such as haemoglobin Alc have been asso-
ciated with an increased risk of microvascular and
macrovascular complications (Peters et al. 1996).
Renal Cd toxicity was found to be more pronounced in
vitamin-C-deficient guinea-pigs than in those fed diets
sufficient in the vitamin (Nagyova et al. 1994). This finding
suggests a role for vitamin C in the prevention of Cd
toxicity, although the biochemical mechanism for such a
protective role of vitamin C remains unclear. Diabetes is
known to be associated with a marginally reduced vitamin
C status (Will et al. 1999), which may be one of the factors
explaining the increased susceptibility to renal Cd toxicity
(Buchet et al. 1990). Indeed, diabetic patients with clinical
nephropathy were found to have lower mean plasma
vitamin C levels, due to higher renal clearance of vitamin
C, than those with microalbuminuria (Hirsch et al. 1998).
However, Cd toxicity in the renal tubular system also
promotes renal vitamin C clearance. Hence, plasma vitamin
C levels might be further reduced in diabetic subjects with
a high Cd body burden. A shortened onset time to renal
failure may result.
High incidence of renal disease and dietary cadmium:
are they linked?
Renal disease and diabetes, particularly the non-insulin-
dependent type, are major health problems faced by
Australian Aboriginals (Spencer et al. 1998). Diabetes
affects 8±24 % of indigenous Australians, compared with
3±4 % among non-indigenous Australians. Torres Strait
Islanders, who live in the northern tip of Queensland, suffer
from even higher rates of diabetes. A much higher
mortality rate has also been recorded among diabetic
Aboriginals as compared with non-diabetic Aboriginals and
non-Aboriginals with or without diabetes. The major cause
of mortality has been renal disease. The complex causes of
this disease are not fully understood, but it has been
suggested that diabetic nephropathy, as well as infection,
high insulin exposure, poor nutrition, smoking and high
blood pressure, may be involved. In general, the median
age for onset of renal failure is lower in indigenous
Australians than their non-indigenous counterparts, and the
condition has a higher incidence among women. Tiwi
residents of Bathurst and Melville islands, north of Darwin
in Northern Territory, have escalating rates of end-stage
renal disease (Spencer et al. 1998).
As previously mentioned, crustaceans and molluscs are
filter feeders and absorb large quantities of Cd from
contaminated waters and sediments. Larger sea animals,
including dugongs (Dugong dugon) and turtles, also
accumulate large amounts of Cd (Dight & Gladstone,
1993; Gordon et al. 1998). The very high levels of Cd in
seafood, especially in offal of dugongs and turtles, (7±
76 mg/kg wet weight) have raised particular concerns,
because they constitute a highly-valued component of the
traditional diet of Torres Strait Islanders and some coastal
Aboriginals. High levels of Fe (12±71 mg/kg dry weight)
have also been found in offal of dugongs (Webb et al.
1999), and this factor may have a considerably effect on Cd
absorption. To date, the role the high Cd levels in
traditional foods plays in the development of renal disease
in Australian Aboriginals has not been well studied.
However, diabetic individuals are at a high risk of Cd-
induced renal tubular dysfunction. Further, if dietary Cd
does have a role, women are more likely to be affected than
men, due to increased Cd absorption associated with
lowered body Fe stores.
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Concluding remarks
Individual variations in sensitivity to toxicity and kidney
Cd accumulation found in human population studies
suggest that a considerable number of individuals may
have toxic levels of Cd in their kidneys, despite the modest
population mean values for Cd body burden. If Cd pollution
continues to increase, so will human dietary Cd exposure,
and renal tubular dysfunction is likely to become more
prevalent in human populations in the next 10±20 years,
particularly in high-risk groups such as those with diabetics
and those with poor vitamin C status, low body Fe stores,
haemochromatosis and marginal Ca or Zn intake. There is a
lack of therapeutically-effective chelating agents to
enhance excretion of Cd from the kidneys, and this factor
makes prevention of kidney Cd accumulation pivotal. The
persistence of this metal in the environment requires a long-
term approach to minimise human exposure through
environmental management and maintenance of lower Cd
levels wherever possible.
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